within Pharmacolibrary.Drugs.ATC.A;

model A10AB03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10AB03</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Insulin (pork) is a biosynthetic polypeptide hormone structurally similar to endogenous human insulin, previously widely used in the management of type 1 and type 2 diabetes mellitus to control blood glucose. Its use has largely been replaced by human insulin and insulin analogues due to concerns about immunogenicity, but it is still available in some countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model parameters reported for healthy adult subjects following subcutaneous injection of purified pork insulin.</p><h4>References</h4><ol><li><p>Tham, LS, et al., &amp; Reviriego, J (2017). Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens. <i>Journal of clinical pharmacology</i> 57(9) 1126–1137. DOI:<a href=\"https://doi.org/10.1002/jcph.899\">10.1002/jcph.899</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28394405/\">https://pubmed.ncbi.nlm.nih.gov/28394405</a></p></li><li><p>Heinemann, L, &amp; Richter, B (1993). Clinical pharmacology of human insulin. <i>Diabetes care</i> 16 Suppl 3 90–100. DOI:<a href=\"https://doi.org/10.2337/diacare.16.3.90\">10.2337/diacare.16.3.90</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8299482/\">https://pubmed.ncbi.nlm.nih.gov/8299482</a></p></li><li><p>Perriello, G, et al., &amp; Bolli, GB (1988). Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. <i>Diabetologia</i> 31(11) 811–815. DOI:<a href=\"https://doi.org/10.1007/BF00277482\">10.1007/BF00277482</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3069528/\">https://pubmed.ncbi.nlm.nih.gov/3069528</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10AB03;
